Maximize Your Impact At Clinical Trials in Oncology Europe 2025
Clinical Trials in Oncology Europe 2025 is a pivotal gathering for clinical operations leaders, clinical trial managers, regulatory strategists, and biotech executives focused on advancing oncology research across Europe. Taking place November 26, 2025, this event is set to bring together key stakeholders driving innovation in cancer drug development, patient recruitment strategy, and regulatory affairs.
Senior professionals from both emerging biotechs and established pharmaceutical companies will attend to discuss clinical trial design, international market access, and evolving partnership models. Many in attendance will be responsible for evaluating CROs, budgeting for upcoming trial phases, and forming cross-border alliances. Early engagement with these decision-makers can provide access to active procurement plans, pilot projects, and technology adoption cycles.
By leveraging the Vendelux enriched attendee list, commercial teams can prioritize outreach by company type, seniority, and region. This ensures you’re speaking to the right stakeholders with relevance and precision ahead of the event.
How Sales, Marketing and Revops Teams Can Use This Attendee List
The attendee list for Clinical Trials in Oncology Europe 2025 contains strategic contacts from sponsor biopharma companies, CROs, clinical technology providers, and regulatory consultancies. Sales and marketing teams can use this data to group outreach by clinical focus area, such as solid tumors vs. rare cancer trials, and tailor messages based on the stage of development or clinical trial phase.
Outreach can target roles like VP of Clinical Development, Head of Regulatory Affairs, or Director of Clinical Operations—positions that own or heavily influence budget decisions. Use attendee data to initiate conversations centered on trial acceleration, site management, or patient data integration, and secure meetings before the event takes place.
Because many deals in this space are relationship-driven, having verified emails and LinkedIn profiles in the enriched conference attendee list allows business development teams to warm up contacts months prior. It also enables follow-ups that reference on-site conversations or panel takeaways. For companies looking to get more meetings and build long-term B2B relationships in oncology research, this list provides the starting point.
Timing Is Everything
Clinical Trials in Oncology Europe 2025 will take place on November 26, 2025. Since most attendees begin evaluating potential partnerships and tools during the summer and fall, the months leading up to the event represent critical windows for early outreach.
By using Vendelux’s attendee list now, teams can book meetings with high-value decision-makers, schedule briefings, and direct content to inform pre-event conversations. This approach ensures brand visibility and aligns sales engagement with trial planning cycles. Starting outreach in May 2025 gives organizations a competitive edge in relationship building and lead generation leading up to the event in Munich.
What’s Included In The Clinical Trials in Oncology Europe 2025 Attendee List?
Vendelux provides visibility into executives expected to attend Clinical Trials in Oncology Europe 2025 using a mix of organizer-supplied lists and predictive data models. Teams can upload their target account lists to find overlapping attendees.
The enriched attendee list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email addresses, and phone numbers where available.
Where Is Clinical Trials in Oncology Europe 2025?
The event will be held at the Marriott Munich City West in Munich, Bayern, Germany.
When Is Clinical Trials in Oncology Europe 2025?
Clinical Trials in Oncology Europe 2025 is scheduled for November 26, 2025.
What Type Of Event Is Clinical Trials in Oncology Europe 2025?
This event is a specialized industry conference focused on clinical development in oncology. It features a mix of keynote presentations, panel discussions, and networking opportunities for professionals involved in trial operations, clinical data, regulatory approvals, and oncology pipeline planning.
How Many People Attend Clinical Trials in Oncology Europe 2025?
The event is expected to attract approximately 250 to 400 attendees from across Europe and North America. Most participants are mid-to-senior level decision-makers from biopharma companies, research institutions, and clinical solution providers.
